Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

First patients receive experimental cancer drug in groundbreaking trial

NCT ID NCT06641908

Recruiting now Disease control Sponsor: EMD Serono Research & Development Institute, Inc. Source: ClinicalTrials.gov ↗

Summary

This is the first human study of an experimental cancer drug called M3554. It aims to find a safe dose and check for early signs that the drug might help control advanced soft tissue sarcomas and glioblastoma brain tumors. The study will enroll about 52 adults whose cancer has progressed after standard treatments. Researchers will closely monitor participants for side effects and any impact on their tumors.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centre Antoine Lacassagne - Service d'Hématologie Oncologie

    RECRUITING

    Nice, France

  • Centre Leon Berard - Service d'Oncologie Medicale

    RECRUITING

    Lyon, France

  • Centre Oscar Lambret - cancerologie generale

    RECRUITING

    Lille, France

  • Dana-Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Institut Bergonié - Service d'Oncologie Médicale

    RECRUITING

    Bordeaux, France

  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc

    WITHDRAWN

    New York, New York, 10022, United States

  • National Cancer Center Hospital

    RECRUITING

    Chūōku, Japan

  • Royal Marsden Hospital-Sutton - Dept of Oncology (Surrey)

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

  • The University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

  • UZ Leuven

    RECRUITING

    Leuven, Belgium

  • Universitaetsspital Zuerich - Klinik fuer Neurologie

    RECRUITING

    Zurich, 8091, Switzerland

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMOR